1 recruiting. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Recruiting 1 |
Follow Pseudomyxoma Peritonei: new trials by email Literature Review of Pseudomyxoma Peritonei trials Research Report on Pseudomyxoma Peritonei
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pseudovax - A Cancer Vaccine for Patients With Pseudomyxoma Peritonei Pseudovax, Molgramostim, Tislelizumab - Pseudomyxoma Peritonei | Early Phase 1 | Recruiting | Oslo University Hospital | 10 | 2025-10-13 | 2026-01-14 |
Adenocarcinoma (1) · Adenocarcinoma, Mucinous (1) · Carcinoma (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Cystic, Mucinous, and Serous (1) · Neoplasms, Glandular and Epithelial (1)
molgramostim (1) · tislelizumab (1)
Norway (1)